Press ReleasesCellular Goods Launches 2-Month 'Outdoor' Marketing Campaign in Manchester...

Cellular Goods Launches 2-Month ‘Outdoor’ Marketing Campaign in Manchester & London


CELLULAR Goods (LSE: CBX), a UK-based wellness company that provides premium consumer products formulated with lab-made cannabinoids, is pleased to announce the launch today of its broadscale two-city outdoor marketing campaign in the UK.

The campaign will run over the next two months and feature advertisements to be displayed at more than 100 digital screens and high impact print billboards across prominent high street locations in London and Manchester. In addition, more than 20 digital screens will feature the advertisements at health and fitness destinations at David Lloyd and Harbour Clubs in London.

The move is part of Cellular Goods’ nationwide marketing campaign which kicked-off with the publication of a white paper highlighting the age prevention benefits of cannabigerol (CBG) and cannabidiol (CBD) used in its products and the start of product sales on Amazon Marketplace from February this year.

The outdoor push is aimed at promoting Cellular Goods’ Look Better (skincare) and Feel Better (supplements) product ranges. The advertisements will appear on different dates and durations on each location.

Anna Chokina, CEO of Cellular Goods, commented: “We’re pleased to announce the beginning of our outdoor marketing campaign which will complement our ongoing national marketing campaign aimed at introducing our brand and premium products to a broad consumer audience. We are committed to continue delivering marketing initiatives to not only continue raising awareness about our brand, but also to teach Britain about cannabinoids and their potential to improve people’s wellness.”

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you